6 results about "Steroidal hormones" patented technology

The present disclosure relates to a method for detecting vitamin D or a steroid hormone and a blood sample pretreatment kit. The method for detecting vitamin D in blood comprises pretreating a blood sample to obtain a test sample, and detecting the test sample by liquid chromatography tandem mass spectrometry, wherein the pretreatment comprises: adding an internal standard solution and a magnetic bead reagent to the blood sample to obtain a mixed solution and incubating to allow the target analyte to bind to the surface of the magnetic beads; separating the magnetic beads combined with the target analyte; and eluting the target analyte from the surface of the magnetic beads to obtain the test sample, wherein the mixed solution comprises methanol in an amount of 45vol% to 60vol%, or ethanol in an amount of 30vol% to 50vol%. The method can significantly reduce non-specific adsorption of magnetic beads, and improve the accuracy and sensitivity of detection.

The application discloses a method for evaluating the influence of human interference on the reproductive health of wild animals. A steroid hormone species and an intestinal microorganism macro-genome assembly genome MAG of a sentinel animal fecal sample are obtained; based on the steroid hormone species, a first gene set is determined, the first gene set comprising a first gene, the first gene being a metabolic enzyme gene, the metabolic enzyme participating in steroid hormone metabolism; based on the first gene set and the MAGs, a first coding sequence CDS set is determined, the first coding sequence CDS set comprising a first CDS, the first CDS being from the MAGs, and the coding region of the first gene comprising the first CDS; based on the first coding sequence CDS set, a first microorganism set HCBs is determined, the HCBs being a collection of host bacteria HCBs of the first CDS, the HCBs being selected from the intestinal flora of the sentinel animal; based on the total relative abundance of the HCBs, it is determined whether human interference affects the reproductive health of wild animals. The method is scientific and reliable, and provides a scientific decision basis for wild animal protection.

This invention discloses a novel use of posaconazole to enhance the immune response in the immunotherapy of breast cancer. Specifically, this invention provides a drug combination comprising posaconazole and a PD-L1 inhibitor. The effects of this invention are: (1) using posaconazole to prepare a drug for treating breast cancer, especially triple-negative breast cancer (TNBC), achieving "repurposing of an old drug"; (2) clarifying its core mechanism of action, clarifying that the anti-tumor effect of clinically commonly used doses of posaconazole depends on the host immune system, rather than traditional direct cytotoxicity, specifically by inhibiting CYP11A1 and other related enzymes in the tumor, thereby reducing immunosuppressive steroid hormones, providing a new drug and target for tumor immunotherapy; (3) providing a technical solution for the combined treatment of posaconazole and PD-L1 inhibitors (such as anti-PD-L1 antibodies), further enhancing anti-tumor immunity and improving the treatment effect of TNBC.

Provided are an estimation device, an estimation method, and a program capable of estimating the steroid hormone concentration in the future from the point of time when data is measured. The estimation device estimates, by using an estimation model that receives physiological data at a certain point of time as an input and outputs an estimation value of the steroid hormone concentration after a prescribed time, a first steroid hormone concentration after a prescribed time by using first physiological data at a certain point of time. The estimation model is a model trained by using second physiological data for training at a certain point of time and a measurement value of a second steroid hormone concentration for training after a prescribed time.

The application discloses a 21-hydroxylase deficiency screening kit and application thereof, relates to the blood analysis technical field, and a steroid hormone marker composition of 21-hydroxylase deficiency, wherein the nine markers comprise 17alpha-hydroxyprogesterone, androstenedione, 11-deoxycortisol, 21-deoxycortisol, cortisol, corticosterone, progesterone, dihydrotestosterone and 11-deoxycorticosterone; the kit can be used for screening 21-hydroxylase deficiency, 11beta-hydroxylase deficiency, 17alpha-hydroxylase deficiency and other types of diseases; the kit comprises detection components for detecting the hormones; compared with a traditional time-resolved fluorescence immunoassay method, the LC-MS / MS multi-index combined detection scheme adopted in the application can significantly reduce false positive results; and invalid recall, unnecessary family anxiety and medical burden caused by false positive results are greatly reduced.

This invention discloses a method for detecting steroid hormones using furoyl chloride derivatization-liquid chromatography-tandem mass spectrometry. This invention utilizes furoyl chloride to derivatize steroid hormones, and the combination with liquid chromatography-tandem mass spectrometry enables highly sensitive and accurate quantification of trace amounts of steroid hormones such as estrone and estradiol in biological matrices. Compared with existing technologies, the method for detecting steroid hormones using furoyl chloride derivatization-liquid chromatography-tandem mass spectrometry provided by this invention exhibits high recovery, a wide linear range, good linearity, low detection limit, and mild reaction conditions with a simplified reaction procedure.